Stock Insiders: Legendary Canadian cannabis entrepreneur Bruce Linton on the sector's future and why he's backing Creso Pharma

Stock Insiders is a new podcast series focussed on investing hosted by renowned business journalist Oriel Morrison. The program is sponsored by Barclay Pearce Capital, Australia’s leading corporate advisory and equities trading firm.

In this episode Oriel chats to cannabis entrepreneur Bruce Linton, founder and former chairman and CEO of Canopy Growth Corporation.

Bruce Linton joined Creso Pharma (ASX:CPH) as a strategic advisor to the $250 million company in October. He reveals what drew him to the company was “its unique intellectual property, global distribution footprint and robust product pipeline targeting distinct categories.”

Creso is a global medicinal cannabis innovator that develops cannabis and hemp-derived therapeutic, nutraceutical and lifestyle products for both people and animals.

To hear more about Bruce’s work with Creso, his entrepreneurial journey in the cannabis sector, overcoming challenges and regulations, the outlook for medicinal cannabis, investment opportunities and more, click below.